Techne (TECH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended December 2025, Techne (TECH) reported revenue of $295.88 million, down 0.4% over the same period last year. EPS came in at $0.46, compared to $0.42 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $292.03 million, representing a surprise of +1.32%. The company delivered an EPS surprise of +8.24%, with the consensus EPS estimate being $0.43.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Techne performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Organic Growth - Diagnostics and Spatial Biology: 3% versus the two-analyst average estimate of 3.9%.Organic Growth - Protein Sciences: -1% versus -2.2% estimated by two analysts on average.Net Sales- Diagnostics and Spatial Biology: $81.18 million compared to the $81.4 million average estimate based on three analysts.Net Sales- Protein Sciences: $215.08 million versus the three-analyst average estimate of $207.1 million. The reported number represents a year-over-year change of +1.7%.Net Sales- Intersegment revenue: $-0.39 million versus the two-analyst average estimate of $-0.45 million. The reported number represents a year-over-year change of -23.2%.View all Key Company Metrics for Techne here>>>Shares of Techne have returned -1% over the past month versus the Zacks S&P 500 composite's +0.9% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.Free Report: Profiting from the 2nd Wave of AI ExplosionThe next phase of the AI explosion is poised to create significant wealth for investors, especially those who get in early. It will add literally trillion of dollars to the economy and revolutionize nearly every part of our lives.Investors who bought shares like Nvidia at the right time have had a shot at huge gains.But the rocket ride in the "first wave" of AI stocks may soon come to an end. The sharp upward trajectory of these stocks will begin to level off, leaving exponential growth to a new wave of cutting-edge companies.Zacks' AI Boom 2.0: The Second Wave report reveals 4 under-the-radar companies that may soon be shining stars of AI’s next leap forward.Access AI Boom 2.0 now, absolutely free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Bio-Techne Corp (TECH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks